DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $576,144 | +24.5% | 2,322 | +20.4% | 0.12% | +33.7% |
Q2 2023 | $462,766 | +3.4% | 1,928 | +8.6% | 0.09% | -5.5% |
Q1 2023 | $447,666 | +2.6% | 1,776 | +8.0% | 0.09% | -3.2% |
Q4 2022 | $436,396 | +0.6% | 1,644 | -2.1% | 0.09% | -9.6% |
Q3 2022 | $434,000 | +16.7% | 1,679 | +14.5% | 0.10% | +13.0% |
Q2 2022 | $372,000 | -18.2% | 1,466 | -5.5% | 0.09% | -9.8% |
Q1 2022 | $455,000 | -9.0% | 1,552 | +2.2% | 0.10% | -11.3% |
Q4 2021 | $500,000 | +16.3% | 1,519 | +7.6% | 0.12% | +9.5% |
Q3 2021 | $430,000 | +44.3% | 1,412 | +27.1% | 0.10% | +40.0% |
Q2 2021 | $298,000 | +18.7% | 1,111 | -0.3% | 0.08% | +8.7% |
Q1 2021 | $251,000 | +2.0% | 1,114 | +0.6% | 0.07% | -1.4% |
Q4 2020 | $246,000 | +18.8% | 1,107 | +15.3% | 0.07% | +11.1% |
Q3 2020 | $207,000 | +109.1% | 960 | +27.7% | 0.06% | +85.3% |
Q1 2019 | $99,000 | +39.4% | 752 | +9.0% | 0.03% | +25.9% |
Q4 2018 | $71,000 | +51.1% | 690 | +59.4% | 0.03% | +58.8% |
Q3 2018 | $47,000 | +9.3% | 433 | 0.0% | 0.02% | +6.2% |
Q2 2018 | $43,000 | 0.0% | 433 | -0.7% | 0.02% | -5.9% |
Q1 2018 | $43,000 | +26.5% | 436 | +16.0% | 0.02% | +21.4% |
Q4 2017 | $34,000 | – | 376 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |